New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 27, 2013
09:18 EDTTWTR, TXT, HLF, WPCS, ANIP, TEVAOn The Fly: Pre-market Movers
HIGHER: Herbalife (HLF), up 1.4% after Wedbush raised its price target on the stock to $90 from $81... ANI Pharmaceuticals (ANIP), up 16% after acquiring 31 previously marketed generic drug products from Teva Pharmaceuticals (TEVA)... WPCS International (WPCS), up 91% after its BTX Trader unit announced the launch of a platform for bitcoin trading. LOWER: Twitter (TWTR), down 4.4% following downgrade to Underperform from Neutral at Macquarie... Textron (TXT), down 0.9% after agreeing to acquire Beechcraft for $1.4B in cash.
News For TWTR;TXT;HLF;WPCS;ANIP;TEVA From The Last 14 Days
Check below for free stories on TWTR;TXT;HLF;WPCS;ANIP;TEVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 8, 2014
08:46 EDTTEVATeva announces first approval, launch of generic Lovaza capsules in the U.S.
Teva (TEVA) announces the approval of the generic equivalent to Lovaza in the United States. Teva believes it is first-to-file and thus far is the only company to receive an approval from FDA. Teva plans to commence shipping immediately. Lovaza Capsules, marketed by GlaxoSmithKline (GSK), had annual sales of approximately $1.1B in the United States, according to IMS data as of December 2013.
06:19 EDTTWTRTwitter initiated with a Buy at Janney Capital
Subscribe for More Information
April 7, 2014
14:09 EDTTEVASun Pharmaceutical agrees to acquire generic drugmaker Ranbaxy
Subscribe for More Information
12:11 EDTTWTRTwitter acquires Cover, terms not disclosed
Subscribe for More Information
06:49 EDTTWTRWeibo looking to raise over $380M in IPO, NY Times says
SINA's (SINA) Weibo hopes to raise more than $380M in its upcoming IPO and price its shares at $17-$19, Weibo said in its prospectus, according to The New York Times. Known as a "microblog," Weibo has been compared to Twitter (TWTR). Reference Link
April 5, 2014
19:30 EDTTWTRTwitter to launch new ad products, WSJ says
In a push to appease e-commerce companies and mobile-game developers, Twitter is planning to debut 15 types of new ad products and ways to target users over the coming six months, says the Wall Street Journal, citing sources. The first group of new adds will be released in a few weeks and will include a product that encourages users to download apps through Twitter, added the Wall Street Journal. Reference Link
April 4, 2014
16:00 EDTTWTROptions Update; April 4, 2014
iPath S&P 500 VIX Short-Term Futures up 89c to 41.88. Option volume leaders: AAPL C P NFLX LNG BAC INTC TSLA TWTR according to Track Data.
11:31 EDTTWTRStocks with call strike movement; JCP TWTR
Subscribe for More Information
10:45 EDTTEVAMylan rises despite Meda rejecting takeover offer
Mylan (MYL) shares are higher this morning following a Financial Times report of its desire to buy Swedish rival Meda. Subsequent to the story being published, Meda confirmed it had been in talks with Mylan but rejected the company's takeover offer. WHAT'S NEW: The Financial Times reported that Mylan was considering buying Meda, a Swedish drugmaker, in a deal that would create a $23B+ pharmaceuticals business. Mylan reportedly hired advisers to put a deal together for Meda, and though the value of a deal was not noted, sources said Mylan was likely to pay a "significant" premium to Meda's market value, which was $4.5B at the end of trading on Thursday. Mylan's market value currently stands at $18.5B. A combination of the drugmakers would create a company with annual revenues of around $9B, the FT said, noting that would be half the size of generic drug rival Teva (TEVA). WHAT'S NOTABLE: Meda's board of directors confirmed that it was contacted by Mylan regarding a proposal to merge the companies, but the board decided to reject the proposal. Meda said all discussions between the company and Mylan have been terminated "without further actions." ANALYST REACTION: Citigroup upgraded Mylan to Buy from Neutral and raised its price target on the stock to $61 from $52 this morning. The firm cited potential operational and tax benefits from an acquisition of Meda, stating that in addition to expanding Mylan's geographic presence, the deal would increase its presence in specialty, OTC and branded generics. OTHER NEWS: Mylan sued Celgene (CELG) to block that company's efforts to keep generic versions of Revlimid and Thalomid off the market, Reuters reported. PRICE ACTION: Mylan shares are up $2.98, or 5.98%, to $52.84 in mid-morning trading.
April 3, 2014
16:00 EDTTWTROptions Update; April 3, 2014
Subscribe for More Information
15:28 EDTTWTRTwitter introduces Vine message service
Subscribe for More Information
14:30 EDTTEVAMylan says USPTO rejects Teva '808 patent reissue application on Copaxone
Subscribe for More Information
14:28 EDTTEVAMylan says USPTO rejects Teva '808 patent reissue application on Copaxone
Subscribe for More Information
12:42 EDTHLFEnergy drink MLM changes practices amid scrutiny of Herbalife, NY Post says
Vemma, a multilevel marketing company that makes Verve brand energy drinks, said it is changing its business practices as the Federal Trade Commission investigates Herbalife (HLF), which has a similar business model, reported The New York Post. Monster Beverage (MNST), which like Herbalife has drawn a fair amount of scrutiny from lawmakers, markets energy drinks that compete with Vemma's. Reference Link
12:37 EDTTWTRTwitter downside accelerates, levels to watch
Subscribe for More Information
11:55 EDTTWTRStocks with call strike movement; JCP TWTR
Subscribe for More Information
10:53 EDTTWTRTwitter ban lifted by Turkey, official says, Reuters reports
Subscribe for More Information
08:03 EDTWPCSWPCS enters definitive agreement to sell Seattle operations
Subscribe for More Information
07:48 EDTHLFChanos says 'side with the bears' on multi-level marketers
Subscribe for More Information
07:44 EDTTWTRTurkey court orders Erdogan government to remove Twitter ban, Bloomberg says
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use